Selective effects of CPAP on sleep apnoea‐associated manifestations

Alexandros N. Vgontzas; E. Zoumakis; Edward O. Bixler; H‐M. Lin; Brett Collins; Maria Basta; S. Pejovic; George Chrousos

doi:10.1111/j.1365-2362.2008.01984.x

Abstract

1 min read

Visceral adiposity and obstructive sleep apnoea (OSA) may be independently associated with daytime sleepiness/low performance, insulin resistance, hypercytokinaemia, and/or hypertension. The objectives of this study are to simultaneously test these associations at baseline and after 3 months of continuous positive airway pressure (CPAP) therapy.

Related publications

Article2003

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance

Alexandros N. Vgontzas, Edward O. Bixler, George Chrousos

Article2012

Sleep apnoea and visceral adiposity in middle-aged male and female subjects

Ilia Kritikou, Maria Basta, Rafel Tappouni, Slobodanha Pejovic, Julio Fernández‐Mendoza, Racha Nazir, Michelle Shaffer, Duanping Liao, Edward O. Bixler, George Chrousos, Alexandros N. Vgontzas

Article2013

Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females

Ilia Kritikou, Maria Basta, Alexandros N. Vgontzas, Slobodanka Pejovic, Duanping Liao, Marina Tsaoussoglou, Edward O. Bixler, Z. Stefanakis, George Chrousos

Article2015

Sleep apnoea and the hypothalamic–pituitary–adrenal axis in men and women: effects of continuous positive airway pressure

Ilia Kritikou, Maria Basta, Alexandros N. Vgontzas, Slobodanka Pejovic, Julio Fernández‐Mendoza, Duanping Liao, Edward O. Bixler, Jordan Gaines, George Chrousos

Article2019

BLOOD PRESSURE EFFECTS OF OBSTRUCTIVE SLEEP APNEA TREATMENT BY CONTINUOUS POSITIVE AIRWAY PRESSURE

Martino F. Pengo, Davide Soranna, Alice Giontella, Elisa Perger, Esther I. Schwarz, Carolina Lombardi, Grzegorz Bilo, Antonella Zambon, Joerg Steier, Pietro Minuz, Gianfranco Parati, Cristiano Fava